MedDataX Logo

Obesity-hypoventilation in Metabolic Syndrom Patients

NCT ID: NCT04839419

Last Updated: 2023-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-01

Study Completion Date

2025-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome in patients with metabolic syndrom.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After being informed about the study and potential risks, patient agreed to participate and undergo :

a functional respiratory exploration, an arterial blood gas analyze, and a polygraphy coupled with a capnography during the same night.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Obesity Hypoventilation Syndrome Capnography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI\>30 kg/m2
* no treatment with CPAP nor NIV

Exclusion Criteria

* obstructive respiratory disease
* non-treated cardiac dysfunction
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SOS Oxygene Mediterranee

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mathieu Despeaux, MD

Role: PRINCIPAL_INVESTIGATOR

Clinique du Chateau de Vernhes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique du Château de Vernhes

Bondigoux, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Delphine Delample, PhD

Role: CONTACT

[email protected]
0612155648 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mathieu Despeaux, MD

Role: primary

[email protected]
0561372727 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A02866-51

Identifier Type: -

Identifier Source: org_study_id